Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing.

Feng J, Zhang Z, Wu X, Mao A, Chang F, Deng X, Gao H, Ouyang C, Dery KJ, Le K, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE.

PLoS One. 2013 Jun 10;8(6):e65033. doi: 10.1371/journal.pone.0065033. Print 2013.

2.

Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.

Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband HB, Gallinger S, Newcomb PA, Hopper JL, Jenkins MA, Casey G, Schumacher F, Chen Z, DeRycke MS, Templeton AS, Winship I, Green RC, Green JS, Macrae FA, Parry S, Young GP, Young JP, Buchanan D, Thomas DC, Bishop DT, Lindor NM, Thibodeau SN, Potter JD, Goode EL; Colon CFR.

PLoS One. 2012;7(5):e38175. doi: 10.1371/journal.pone.0038175. Epub 2012 May 31. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/1ba2f5e3-8aef-4a12-909b-23f95a889325.

3.

Three ways of combining genotyping and resequencing in case-control association studies.

Longmate JA, Larson GP, Krontiris TG, Sommer SS.

PLoS One. 2010 Dec 20;5(12):e14318. doi: 10.1371/journal.pone.0014318.

4.

Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels.

Feng J, Zhang Z, Li W, Shen X, Song W, Yang C, Chang F, Longmate J, Marek C, St Amand RP, Krontiris TG, Shively JE, Sommer SS.

PLoS One. 2009 Dec 30;4(12):e8480. doi: 10.1371/journal.pone.0008480.

5.

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG, Weitzel J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Larson GP.

Cancer Res. 2009 Sep 15;69(18):7459-65. doi: 10.1158/0008-5472.CAN-09-1201. Epub 2009 Sep 8.

6.

Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk.

Ding Y, Larson G, Rivas G, Lundberg C, Geller L, Ouyang C, Weitzel J, Archambeau J, Slater J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Nordborg M, Krontiris TG.

PLoS One. 2008;3(10):e3533. doi: 10.1371/journal.pone.0003533. Epub 2008 Oct 27.

7.

Evolutionary signatures of common human cis-regulatory haplotypes.

Ouyang C, Smith DD, Krontiris TG.

PLoS One. 2008;3(10):e3362. doi: 10.1371/journal.pone.0003362. Epub 2008 Oct 10.

8.

Matchmaking, metrics and money: a pathway to progress in translational research.

Krontiris TG, Rubenson D.

Bioessays. 2008 Oct;30(10):1025-9. doi: 10.1002/bies.20826.

PMID:
18800381
9.

SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage.

Tan JA, Sun Y, Song J, Chen Y, Krontiris TG, Durrin LK.

J Biol Chem. 2008 Jun 27;283(26):18124-34. doi: 10.1074/jbc.M800512200. Epub 2008 Apr 11.

10.
11.

Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.

Larson GP, Ding Y, Cheng LS, Lundberg C, Gagalang V, Rivas G, Geller L, Weitzel J, MacDonald D, Archambeau J, Slater J, Neuberg D, Daly MB, Angel I, Benson AB 3rd, Smith K, Kirkwood JM, O'Dwyer PJ, Raskay B, Sutphen R, Drew R, Stewart JA, Werndli J, Johnson D, Ruckdeschel JC, Elston RC, Krontiris TG.

Cancer Res. 2005 Feb 1;65(3):805-14.

12.

Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.

Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y.

Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14373-8. Epub 2004 Sep 23.

13.

The HRAS1 variable number of tandem repeats and risk of breast cancer.

Tamimi RM, Hankinson SE, Ding S, Gagalang V, Larson GP, Spiegelman D, Colditz GA, Krontiris TG, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1528-30.

14.

Specific interaction of PML bodies with the TP53 locus in Jurkat interphase nuclei.

Sun Y, Durrin LK, Krontiris TG.

Genomics. 2003 Aug;82(2):250-2.

PMID:
12837275
16.

Expression and replication timing patterns of wildtype and translocated BCL2 genes.

Sun Y, Wyatt RT, Bigley A, Krontiris TG.

Genomics. 2001 Apr 15;73(2):161-70.

PMID:
11318606
17.

PCR candidate region mismatch scanning: adaptation to quantitative, high-throughput genotyping.

Beaulieu M, Larson GP, Geller L, Flanagan SD, Krontiris TG.

Nucleic Acids Res. 2001 Mar 1;29(5):1114-24.

18.

Re: HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.

Krontiris TG.

J Natl Cancer Inst. 2000 May 3;92(9):755-7. No abstract available.

PMID:
10793113
19.

Re: HRAS1 rare minisatellite alleles and breast cancer in australian women under age forty years

Krontiris TG.

J Natl Cancer Inst. 2000 May 3;92(9):755A-756. No abstract available.

PMID:
10793115
20.

The HRAS1 minisatellite locus and risk of ovarian cancer.

Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG.

Cancer Res. 2000 Jan 15;60(2):259-61.

21.

Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2.

Ramakrishnan M, Liu WM, DiCroce PA, Posner A, Zheng J, Kohwi-Shigematsu T, Krontiris TG.

Mol Cell Biol. 2000 Feb;20(3):868-77.

22.

Instability of the EPM1 minisatellite.

Larson GP, Ding S, Lafrenière RG, Rouleau GA, Krontiris TG.

Hum Mol Genet. 1999 Oct;8(11):1985-8.

PMID:
10484766
23.

Distinct mutation patterns of breast cancer-associated alleles of the HRAS1 minisatellite locus.

Ding S, Larson GP, Foldenauer K, Zhang G, Krontiris TG.

Hum Mol Genet. 1999 Mar;8(3):515-21.

PMID:
9949211
24.

An allelic variant at the ATM locus is implicated in breast cancer susceptibility.

Larson GP, Zhang G, Ding S, Foldenauer K, Udar N, Gatti RA, Neuberg D, Lunetta KL, Ruckdeschel JC, Longmate J, Flanagan S, Krontiris TG.

Genet Test. 1997-1998;1(3):165-70.

PMID:
10464642
25.

The BCL2 major breakpoint region is a sequence- and cell-cycle-specific binding site of the Ku antigen.

DiCroce PA, Krontiris TG.

Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10137-41.

26.

Minisatellites and human disease.

Krontiris TG.

Science. 1995 Sep 22;269(5231):1682-3. No abstract available.

PMID:
7569893
27.

Oncogenes.

Krontiris TG.

N Engl J Med. 1995 Aug 3;333(5):303-6. Review. No abstract available.

PMID:
7596376
28.

An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.

Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N.

N Engl J Med. 1993 Aug 19;329(8):517-23.

29.

Allelic variation of reporter gene activation by the HRAS1 minisatellite.

Green M, Krontiris TG.

Genomics. 1993 Aug;17(2):429-34.

PMID:
8406494
31.

Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

Weston A, Caporaso NE, Perrin LS, Sugimura H, Tamai S, Krontiris TG, Trump BF, Hoover RN, Harris CC.

Environ Health Perspect. 1992 Nov;98:61-7.

32.

The HRAS1 gene cluster: two upstream regions recognizing transcripts and a third encoding a gene with a leucine zipper domain.

Weitzel JN, Kasperczyk A, Mohan C, Krontiris TG.

Genomics. 1992 Oct;14(2):309-19.

PMID:
1339391
33.

BCL2 oncogene translocation is mediated by a chi-like consensus.

Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG.

J Exp Med. 1992 Jun 1;175(6):1575-88.

34.
35.

Racial variation in the distribution of Ha-ras-1 alleles.

Weston A, Vineis P, Caporaso NE, Krontiris TG, Lonergan JA, Sugimura H.

Mol Carcinog. 1991;4(4):265-8.

PMID:
1714739
36.

Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus.

Kasperczyk A, DiMartino NA, Krontiris TG.

Am J Hum Genet. 1990 Nov;47(5):854-9.

37.

Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.

Sugimura H, Caporaso NE, Modali RV, Hoover RN, Resau JH, Trump BF, Longergan JA, Krontiris TG, Mann DL, Weston A, et al.

Cancer Res. 1990 Mar 15;50(6):1857-62.

38.

The human minisatellite consensus at breakpoints of oncogene translocations.

Krowczynska AM, Rudders RA, Krontiris TG.

Nucleic Acids Res. 1990 Mar 11;18(5):1121-7.

39.

Detection of cancer predisposition by hypervariable region analysis.

Krontiris TG.

Birth Defects Orig Artic Ser. 1990;26(1):129-40. Review. No abstract available.

PMID:
2224075
40.

Allele-specific deletion in exon I of the HRAS1 gene.

Kasperczyk A, Mermer BA, Parkinson DR, Lonergan JA, Krontiris TG.

Am J Hum Genet. 1989 Nov;45(5):689-96.

41.
42.

Oncogenes and human malignancy.

Wagner RF Jr, Krontiris TG.

Adv Dermatol. 1988;3:277-92. Review. No abstract available.

PMID:
3152824
43.

Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.

Krontiris TG, DiMartino NA, Mitcheson HD, Lonergan JA, Begg C, Parkinson DR.

Environ Health Perspect. 1987 Dec;76:147-53.

44.

A family of short, interspersed repeats is associated with tandemly repetitive DNA in the human genome.

Mermer B, Colb M, Krontiris TG.

Proc Natl Acad Sci U S A. 1987 May;84(10):3320-4.

45.

A variable tandem repeat locus mapped to chromosome band 10q26 is amplified and rearranged in leukocyte DNAs of two cancer patients.

Colb M, Yang-Feng T, Francke U, Mermer B, Parkinson DR, Krontiris TG.

Nucleic Acids Res. 1986 Oct 24;14(20):7929-37.

46.

Human restriction fragment length polymorphisms and cancer risk assessment.

Krontiris TG, DiMartino NA, Colb M, Mitcheson HD, Parkinson DR.

J Cell Biochem. 1986;30(4):319-29.

PMID:
3011817
47.

Oncogenes.

Colb M, Krontiris TG.

Adv Intern Med. 1986;31:47-70. Review.

PMID:
3004124
48.

Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders.

Aisenberg AC, Krontiris TG, Mak TW, Wilkes BM.

N Engl J Med. 1985 Aug 29;313(9):529-33.

PMID:
2862584
49.

Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Krontiris TG, DiMartino NA, Colb M, Parkinson DR.

Nature. 1985 Jan 31-Feb 6;313(6001):369-74.

PMID:
2578622
50.

The emerging genetics of human cancer.

Krontiris TG.

N Engl J Med. 1983 Aug 18;309(7):404-9. Review.

PMID:
6348538

Supplemental Content

Loading ...
Support Center